Company intelligence / Profile preview

Sephytal Pharma

Ownership
Private
Development stage
Other
01

Overview

Sephytal Pharma is a biotechnology company focused on the discovery and development of innovative therapeutic solutions derived from natural sources. The company specializes in identifying bioactive compounds from plants and marine organisms to address unmet medical needs in inflammatory diseases, pain management, and dermatology. By leveraging advanced extraction and purification technologies, Sephytal Pharma aims to bridge the gap between traditional natural medicine and modern pharmaceutical standards. Their research programs are currently in the pre-clinical stage, focusing on validating the efficacy and safety of their lead candidates.

Therapeutic areas
ImmunologyNeurologyDermatology
Modalities
Small moleculeNatural products
Industry
Biotech

Beyond the preview

Go deeper on Sephytal Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sephytal Pharma.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call